Suzuken Co., Ltd. (TYO: 9987)
Japan
· Delayed Price · Currency is JPY
4,725.00
+11.00 (0.23%)
Jan 21, 2025, 9:38 AM JST
Suzuken Revenue
Suzuken had revenue of 615.13B JPY in the quarter ending September 30, 2024, a decrease of -0.92%. This brings the company's revenue in the last twelve months to 2.39T, up 0.77% year-over-year. In the fiscal year ending March 31, 2024, Suzuken had annual revenue of 2.39T with 3.10% growth.
Revenue (ttm)
2,389.34B
Revenue Growth
+0.77%
P/S Ratio
0.15
Revenue / Employee
182.59M
Employees
13,086
Market Cap
366.05B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 2,386.49B | 71.67B | 3.10% |
Mar 31, 2023 | 2,314.83B | 82.05B | 3.67% |
Mar 31, 2022 | 2,232.77B | 104.56B | 4.91% |
Mar 31, 2021 | 2,128.22B | -85.26B | -3.85% |
Mar 31, 2020 | 2,213.48B | 81.12B | 3.80% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,142.35B |
Daiichi Sankyo Company | 1,758.07B |
HOYA Corporation | 812.74B |
Takeda Pharmaceutical Company | 4,546.08B |
Otsuka Holdings | 2,269.56B |
Terumo | 986.67B |
Astellas Pharma | 1,772.16B |
Olympus | 973.60B |